Mycetoma by Actinomadura madurae in the central nervous system: Renal transplant receptor disease [PDF]
Clinical Case Reports, 2022 The mycetoma is a granulomatous chronic disease, subcutaneous disease is the common presentation, very few cases are reported affecting central nervous system, but there are not cases in Renal Transplant (RT).
José Ignacio Cerrillos‐Gutiérrez +5 more
doaj +5 more sources
Actinomycetoma by Actinomadura madurae: Clinical characteristics and treatment of 47 cases [PDF]
Indian Dermatology Online Journal, 2021 Context: Mycetoma is a chronic, granulomatous disease caused by fungi (eumycetoma) or aerobic filamentous actinomycetes (actinomycetoma). Actinomadura madurae is one of the most frequent actinomycetes. Aim: The study aims to provide an update on clinical,
Alexandro Bonifaz +4 more
doaj +4 more sources
Orbital actinomadura madurae actinomycetoma: Case report and literature review. [PDF]
PLoS Neglected Tropical DiseasesThe reported patient is a middle-aged farmer from West Sudan who presented with a painless mass in the right upper eyelid that progressively enlarged over time. His medical treatment journey was prolonged and difficult.
Omayma Abdulazeem Abbass +4 more
doaj +4 more sources
Systematic whole-genome sequencing reveals an unexpected diversity among actinomycetoma pathogens and provides insights into their antibacterial susceptibilities. [PDF]
PLoS Neglected Tropical Diseases, 2022 Mycetoma is a neglected tropical chronic granulomatous inflammatory disease of the skin and subcutaneous tissues. More than 70 species with a broad taxonomic diversity have been implicated as agents of mycetoma.
Andrew Keith Watson +10 more
doaj +5 more sources
Global burden of human mycetoma: a systematic review and meta-analysis. [PDF]
PLoS Neglected Tropical Diseases, 2013 Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known.
Wendy W J van de Sande
doaj +17 more sources
Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report [PDF]
BMC Infectious Diseases, 2020 Background Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries.
Arezki Izri +8 more
doaj +2 more sources
Actinomadura welshii sp. nov., a New Mycetoma Agent in Mexico. [PDF]
PLoS Neglected Tropical DiseasesActinomadura isolates obtained from seven human mycetoma cases in Mexico were characterized using nucleotide sequence analysis of a portion of the small subunit ribosomal RNA gene. Most isolates were identified as Actinomadura madurae.
Lucio Vera-Cabrera +8 more
doaj +2 more sources
Eumycotic mycetoma involving the right foot: A new Tunisian case. [PDF]
Clin Case Rep, 2022 A Tunisian patient with painless swelling and discharging sinuses of the right foot was diagnosed with eumycetoma after 1 year of evolution. Mycetoma is a neglected disease relatively rare in our country. An early and accurate diagnosis, based on histopathological and microbiological examinations, limits functional and esthetical damage.
Ben Tekaya A +7 more
europepmc +2 more sources
Susceptibility of three clinical isolates of Actinomodura madurae to α-pinene, the bioactive agent of Pinus pinaster turpentine oil [PDF]
Archives of Biological Sciences, 2008 In vitro susceptibility of the turpentine oil obtained from Pinus pinaster oleoresin was evaluated against three Sudanese clinical isolates of Actinomadura madurae, which is the main causative agent of actinomycetoma.
Stojković D. +8 more
doaj +4 more sources
Diagnostics to support mycetoma management-Development of two target product profiles. [PDF]
Trop Med Int Health, 2022 Abstract Objective Mycetoma is a neglected tropical disease caused by more than 70 different microorganisms and identified by the WHO as one of the high‐priority diseases for developing diagnostic tests. To ensure the production of diagnostic assays for use by clinical staff in endemic regions, target product profiles (TPPs) were designed.
Fongwen N +13 more
europepmc +2 more sources